{"id":"2282f339-b758-556b-826c-869983f7b249","stable_key":"e69ef6a0-0e23-5eac-aca1-cf333781b962:ino-kir-flow-rescue","predicate":"restores","statement":"Soluble PIP2 administration restored Kir2.1-dependent neurovascular responses in the studied mouse model.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"3ae68fa0-4c4e-5b66-b1e7-e682780e4a58","mechanism_event_label":"Replacing the deficient lipid signal restored a blood-flow response in these mice.","subject":{"id":"af38e50f-cdfb-5d4b-a6fb-f742d1b23d41","slug":"phosphatidylinositol-4-5-bisphosphate","display_name":"Phosphatidylinositol 4,5-bisphosphate","entity_type_key":"lipid"},"object":{"id":"14dda5b8-dc1f-579f-b4b3-312e6e3317ee","slug":"functional-hyperemia","display_name":"Neural-activity-evoked cerebral blood flow","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"3ae68fa0-4c4e-5b66-b1e7-e682780e4a58","stable_key":"e69ef6a0-0e23-5eac-aca1-cf333781b962:ino-kir-flow-rescue-event","event_type":"biochemical_relationship","label":"Replacing the deficient lipid signal restored a blood-flow response in these mice.","description":"Soluble PIP2 administration restored Kir2.1-dependent neurovascular responses in the studied mouse model.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"4d012859-3e1a-523d-b9bf-eccdbc02cb8e","slug":"mouse-kcnj2","display_name":"Mouse Kcnj2 (Kir2.1)","entity_type_key":"protein"},"role":"channel","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"af38e50f-cdfb-5d4b-a6fb-f742d1b23d41","slug":"phosphatidylinositol-4-5-bisphosphate","display_name":"Phosphatidylinositol 4,5-bisphosphate","entity_type_key":"lipid"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"14dda5b8-dc1f-579f-b4b3-312e6e3317ee","slug":"functional-hyperemia","display_name":"Neural-activity-evoked cerebral blood flow","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/inositol-research/33875602.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"139eeba386e63329898f8e36ebe93ad741eed904819bbebe7fc2b1808130a19d\", \"start_char\": 0, \"end_char\": 1108, \"text_sha256\": \"139eeba386e63329898f8e36ebe93ad741eed904819bbebe7fc2b1808130a19d\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Genetic small-vessel disease mouse model and lipid rescue","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"PIP2 depletion and soluble PIP2 administration","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Mouse disease model; not evidence that oral inositol treats human cerebrovascular disease.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Inositol research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"inositol","display_name":"Inositol (stereoisomer family)","entity_type_key":"chemical_species"}},{"dimension":"organism","value_text":"Mus musculus","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Replacing the deficient lipid signal restored a blood-flow response in these mice.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[ino-p33875602] PIP2 corrects cerebral blood flow deficits in small vessel disease by rescuing capillary Kir2.1 activity. (2021). https://pubmed.ncbi.nlm.nih.gov/33875602/ DOI: 10.1073/pnas.2025998118","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Brain capillary endothelium and cerebral circulation","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"497ae226-79fe-5c0f-a574-1f497e7b0c08","evidence_kind":"source_excerpt","locator":"Lines 1029-1040","start_line":1029,"end_line":1040,"excerpt":"### ino-kir-flow-rescue\nSoluble PIP2 administration restored Kir2.1-dependent neurovascular responses in the studied mouse model.\nCondition category: machinery_impairment\nnutrient_topic: Inositol research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: Replacing the deficient lipid signal restored a blood-flow response in these mice.\norganism: Mus musculus\ntissue_or_cell_type: Brain capillary endothelium and cerebral circulation\nexperimental_model: Genetic small-vessel disease mouse model and lipid rescue\nlimitations: Mouse disease model; not evidence that oral inositol treats human cerebrovascular disease.\nexposure: PIP2 depletion and soluble PIP2 administration\nevidence_span: {\"source_cache\": \"artifacts/inositol-research/33875602.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"139eeba386e63329898f8e36ebe93ad741eed904819bbebe7fc2b1808130a19d\", \"start_char\": 0, \"end_char\": 1108, \"text_sha256\": \"139eeba386e63329898f8e36ebe93ad741eed904819bbebe7fc2b1808130a19d\"}\n[ino-p33875602] PIP2 corrects cerebral blood flow deficits in small vessel disease by rescuing capillary Kir2.1 activity. (2021). https://pubmed.ncbi.nlm.nih.gov/33875602/ DOI: 10.1073/pnas.2025998118","model_system":"Genetic small-vessel disease mouse model and lipid rescue","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [ino-p33875602] PIP2 corrects cerebral blood flow deficits in small vessel disease by rescuing capillary Kir2.1 activity. (2021). https://pubmed.ncbi.nlm.nih.gov/33875602/ DOI: 10.1073/pnas.2025998118","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"d590c659-b774-50e6-9f1d-aff61d5f7c9c","stable_key":"import-e69ef6a0-0e23-5eac-aca1-cf333781b962","title":"Inositol: synthesis, signaling, mineral interactions and conditional deficiency (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"f7adbcedad647d5f8a3cc9e46bfa515e83c508be9c2a4e9d59c5f5dfb0667d53","revision_id":"a82d187c-60fb-52d1-8482-eadb92860f33","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}